These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 26603552)

  • 1. Is fucose the answer to the immunomodulatory paradox of Quillaja saponins?
    Marciani DJ
    Int Immunopharmacol; 2015 Dec; 29(2):908-913. PubMed ID: 26603552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of N-acylation on the immune adjuvanticity of analogs of the Quillaja saponins derivative GPI-0100.
    Marciani DJ
    Vaccine; 2022 Jul; 40(31):4169-4173. PubMed ID: 35688726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immunomodulators on the response induced by vaccines against autoimmune diseases.
    Marciani DJ
    Autoimmunity; 2017 Nov; 50(7):393-402. PubMed ID: 28906131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants.
    Marciani DJ
    Trends Pharmacol Sci; 2018 Jun; 39(6):573-585. PubMed ID: 29655658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel ISCOMs from Quillaja brasiliensis saponins induce mucosal and systemic antibody production, T-cell responses and improved antigen uptake.
    Cibulski SP; Mourglia-Ettlin G; Teixeira TF; Quirici L; Roehe PM; Ferreira F; Silveira F
    Vaccine; 2016 Feb; 34(9):1162-71. PubMed ID: 26826546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saponins from
    Fleck JD; Betti AH; da Silva FP; Troian EA; Olivaro C; Ferreira F; Verza SG
    Molecules; 2019 Jan; 24(1):. PubMed ID: 30621160
    [No Abstract]   [Full Text] [Related]  

  • 7. Foamy matters: an update on
    Magedans YV; Yendo AC; Costa F; Gosmann G; Fett-Neto AG
    Future Med Chem; 2019 Jun; 11(12):1485-1499. PubMed ID: 31304830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fucose-specific DC-SIGN signalling directs T helper cell type-2 responses via IKKε- and CYLD-dependent Bcl3 activation.
    Gringhuis SI; Kaptein TM; Wevers BA; Mesman AW; Geijtenbeek TB
    Nat Commun; 2014 May; 5():3898. PubMed ID: 24867235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fractionation, structural studies, and immunological characterization of the semi-synthetic Quillaja saponins derivative GPI-0100.
    Marciani DJ; Reynolds RC; Pathak AK; Finley-Woodman K; May RD
    Vaccine; 2003 Sep; 21(25-26):3961-71. PubMed ID: 12922132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Th2 adjuvants for preventive and active immunotherapy of neurodegenerative proteinopathies.
    Marciani DJ
    Drug Discov Today; 2014 Jul; 19(7):912-20. PubMed ID: 24607730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of semisynthetic triterpenoid saponin derivatives with immune stimulating activity.
    Marciani DJ; Press JB; Reynolds RC; Pathak AK; Pathak V; Gundy LE; Farmer JT; Koratich MS; May RD
    Vaccine; 2000 Jul; 18(27):3141-51. PubMed ID: 10856794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rabies vaccine adjuvanted with saponins from leaves of the soap tree (Quillaja brasiliensis) induces specific immune responses and protects against lethal challenge.
    Yendo AC; de Costa F; Cibulski SP; Teixeira TF; Colling LC; Mastrogiovanni M; Soulé S; Roehe PM; Gosmann G; Ferreira FA; Fett-Neto AG
    Vaccine; 2016 Apr; 34(20):2305-11. PubMed ID: 27032516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins.
    Marciani DJ; Pathak AK; Reynolds RC; Seitz L; May RD
    Int Immunopharmacol; 2001 Apr; 1(4):813-8. PubMed ID: 11357894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and Evaluation of a QS-17/18-Based Vaccine Adjuvant.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    J Med Chem; 2019 Feb; 62(3):1669-1676. PubMed ID: 30656932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and Evaluation of QS-7-Based Vaccine Adjuvants.
    Wang P; Škalamera Đ; Sui X; Zhang P; Michalek SM
    ACS Infect Dis; 2019 Jun; 5(6):974-981. PubMed ID: 30920199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulatory activity of Asparagus racemosus on systemic Th1/Th2 immunity: implications for immunoadjuvant potential.
    Gautam M; Saha S; Bani S; Kaul A; Mishra S; Patil D; Satti NK; Suri KA; Gairola S; Suresh K; Jadhav S; Qazi GN; Patwardhan B
    J Ethnopharmacol; 2009 Jan; 121(2):241-7. PubMed ID: 19038322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IMXQB-80: A Quillaja brasiliensis saponin-based nanoadjuvant enhances Zika virus specific immune responses in mice.
    Cibulski S; Teixeira TF; Varela APM; de Lima MF; Casanova G; Nascimento YM; Fechine Tavares J; da Silva MS; Sesterheim P; Souza DO; Roehe PM; Silveira F
    Vaccine; 2021 Jan; 39(3):571-579. PubMed ID: 33339669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD30 antigen and multiple sclerosis: CD30, an important costimulatory molecule and marker of a regulatory subpopulation of dendritic cells, is involved in the maintenance of the physiological balance between TH1/TH2 immune responses and tolerance. The role of IFNbeta-1a in the treatment of multiple sclerosis.
    Pellegrini P; Totaro R; Contasta I; Berghella AM; Carolei A; Adorno D
    Neuroimmunomodulation; 2005; 12(4):220-34. PubMed ID: 15990453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophoretic mobility as a tool to separate immune adjuvant saponins from Quillaja saponaria Molina.
    Gilabert-Oriol R; Weng A; von Mallinckrodt B; Stöshel A; Nissi L; Melzig MF; Fuchs H; Thakur M
    Int J Pharm; 2015 Jun; 487(1-2):39-48. PubMed ID: 25839418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quillaja Saponin Characteristics and Functional Properties.
    Reichert CL; Salminen H; Weiss J
    Annu Rev Food Sci Technol; 2019 Mar; 10():43-73. PubMed ID: 30664381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.